Vaxcyte (PCVX) Exchange Rate Effect (2021 - 2026)
Vaxcyte's (PCVX) quarterly Exchange Rate Effect came in at -$664000.0 in Q1 2026, down 156.66% year-on-year from $1.2 million in Q1 2025, and down 477.27% on a QoQ basis from $176000.0 in Q4 2025.
Vaxcyte (PCVX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 6 years of Exchange Rate Effect data on file, last reported at -$664000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 156.66% year-over-year to -$664000.0 in Q1 2026; TTM through Mar 2026 was $603000.0, a 113.51% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 472.54% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$664000.0, down from $176000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for PCVX reached as high as $6.1 million in Q1 2024 and fell as low as -$7.7 million in Q4 2023.
- Historically, Exchange Rate Effect has averaged -$255764.7 across 5 years, with a median of $53000.0 in 2022.
- On a YoY basis, Exchange Rate Effect climbed as much as 26256.52% in 2024 and fell as far as 1707.69% in 2024.
- Year by year, Exchange Rate Effect stood at $796000.0 in 2022, then slumped by 1065.08% to -$7.7 million in 2023, then soared by 117.57% to $1.3 million in 2024, then slumped by 86.96% to $176000.0 in 2025, then slumped by 477.27% to -$664000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$664000.0 in Q1 2026, $176000.0 in Q4 2025, and $291000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Vaxcyte | 7.64 Bn | 7.64 Bn | - | -664,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -664,000.00 |
| Mar 31, 2026 | -664,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -5.58 Mn |
| Sep 30, 2024 | -5.58 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Mar 31, 2024 | 6.06 Mn |
| Mar 31, 2024 | 6.06 Mn |
| Dec 31, 2023 | -7.68 Mn |
| Dec 31, 2023 | -7.68 Mn |